Dr. Hans-Lothar ArthDr. Jennifer BaltesDr. Dianne SnowdenBoo Geun KIM, Ph.D.Oliviana C─âlin, Ph.D.Dipl.-Chem. Senada DuricTianna Dauner, J.D.M.Sc. Limin Siebert-SuDipl.-Ing. Kirstin Bettin

Stent

Dr. Hans-Lothar Arth

Hans-Lothar Arth is a European and German Patent Attorney and European Trademark and Design Attorney.

Dr. Arth obtained his Doctorate in chemistry in 1997. For his studies he received an award of the German Chemical Society.

Dr. Arth specializes in chemistry, pharmacy, biotechnology, medicine, and especially in organic, polymer, and enzymatic chemistry, asymmetric synthesis, drug development, pharmaceutically active agents, and oil and gas exploration.

During his Doctorate, Dr. Arth synthesized chiral derivatives of natural products, designed assays, and prepared enzymes such as aldolases.

During his 15-months of post-doctoral work at the Ohio State University (Columbus, Ohio, U.S.A.), Dr. Arth was involved in the synthesis of a new anti-cancer drug.

Before founding his own patent law firm, Dr. Arth worked 1.5 years with the pharmaceutical company Axxima Pharmaceuticals AG in Munich where he established the company's intellectual property department. He represented this pharmaceutical company at a financing round of about 40 million Euros.

Within the past few years Dr. Arth supported various companies at initial public offerings and financial rounds, represented companies towards investors and evaluated IP-portfolios and scientific projects for investors.

Furthermore Dr. Arth supported companies at a IP-strategic product development and the IP-portfolio management.

Dr. Arth is a member of VPP and FICPI.